Home
>
National Drug Code (NDC)
>
Tizanidine Hydrochloride
Tizanidine Hydrochloride - 0378-1666-19 - (tizanidine hydrochloride)
Drug Information of Tizanidine Hydrochloride
| Product NDC: | 0378-1666 |
| Proprietary Name: | Tizanidine Hydrochloride |
| Non Proprietary Name: | tizanidine hydrochloride |
| Active Ingredient(s): | 4 mg/1 & nbsp; tizanidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tizanidine Hydrochloride
| Product NDC: | 0378-1666 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091502 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121109 |
Package Information of Tizanidine Hydrochloride
| Package NDC: | 0378-1666-19 |
| Package Description: | 150 CAPSULE in 1 BOTTLE, PLASTIC (0378-1666-19) |
NDC Information of Tizanidine Hydrochloride
| NDC Code | 0378-1666-19 |
| Proprietary Name | Tizanidine Hydrochloride |
| Package Description | 150 CAPSULE in 1 BOTTLE, PLASTIC (0378-1666-19) |
| Product NDC | 0378-1666 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tizanidine hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121109 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
